Skip to main content
OMNICELL, INC. logo

OMNICELL, INC. — Investor Relations & Filings

Ticker · OMCL ISIN · US68213N1090 LEI · 5493008RH0GTKHHPZI77 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Filings indexed 1,420 across all filing types
Latest filing 2023-04-06 Proxy Solicitation & In…
Country US United States of America
Listing US OMCL

About OMNICELL, INC.

https://www.omnicell.com/

Omnicell, Inc. is a healthcare technology company that provides medication management solutions for healthcare systems and pharmacies. The company develops automation systems, robotics, and cloud-based intelligence platforms centered on the vision of the Autonomous Pharmacy. Its offerings include automated dispensing systems, medication adherence tools, and expert services designed to automate medication and supply workflows. By integrating these technologies, Omnicell aims to enhance operational efficiency, reduce the potential for human error, improve patient safety, and optimize clinical and financial outcomes for healthcare providers.

Recent filings

Filing Released Lang Actions
DEF 14A
Proxy Solicitation & Information Statement
2023-04-06 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement, specifically a second amendment to a credit agreement involving changes to the interest rate benchmark from LIBOR to SOFR. This is a financing-related update about the company's debt arrangements. The document does not contain financial statements or detailed financial analysis but focuses on a financing amendment. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is 4517 characters, which is consistent with a detailed announcement rather than a brief notice or a full financial report. Hence, the classification is CAP with high confidence.
2023-04-03 English
Director's Dealing 2023
Director's Dealing
2023-03-17 English
Director's Dealing 2023
Director's Dealing
2023-03-17 English
Director's Dealing 2023
Director's Dealing
2023-03-09 English
10-K
Annual Report FY 2022
2023-03-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.